Closed tender · Germany · Contract notice
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Erythropoetin (ausschließlich Epoetin zeta), (OBO), ATC B03XA01 für die Zeit 01.12.2024 - 30.11.2026
In EnglishConclusion of a non-exclusive discount agreement under § 130a para. 8 SGB V for the active ingredient Erythropoietin (excluding Epoetin zeta), (OBO), ATC B03XA01 for the period 01.12.2024 - 30.11.2026
DAK-Gesundheit in Germany invited bids for “Conclusion of a non-exclusive discount agreement under § 130a para. 8 SGB V for the active ingredient Erythropoietin (excluding Epoetin zeta), (OBO)…”. Bids closed on 5 October 2026.
The work
Conclusion of a non-exclusive discount agreement for the active substance Erythropoetin (exclusively Epoetin zeta), ATC B03XA01, for the period 01.12.2024 - 30.11.2026.
Public data: TED – Tenders Electronic Daily. © European Union, 1998–2026. Notices reused under Commission Decision 2011/833/EU. · Sources & licences